Genetic products differentially expressed in tumors and the use thereof
AssigneeGanymed Pharmaceuticals AG
InventorsÖzlem Türeci, Ugur Sahin, Michael Koslowski, Stefan Fritz, Harald-Gerhard Geppert
Life of this patent
Estimating the term…
Abstract
According to the invention, gene products expressed in a tumor-associated manner and the nucleic acids coding therefor were identified. The invention relates to the therapy and diagnosis of diseases wherein said gene products expressed in a tumor-associated manner are aberrantly expressed. The invention also relates to proteins, polypeptides and peptides which are expressed in a tumor associated manner and to nucleic acids coding therefor.
Claims7
A method of treating a disease characterized by expression of a tumor-associated antigen that (a) is encoded by a nucleic acid which comprises a nucleic acid sequence of SEQ ID NO:
- 7 or (b) comprises the amino acid sequence of SEQ ID NO:
- 16, comprising administering to a patient suffering from said disease an antibody that selectively binds to the tumor-associated antigen, wherein said disease is lung tumor or a pancreatic tumor.
Dependencies are inferred from the claim text.